DCGO DocGo Price-to-Projected Revenue Ratio

docgo.com - graphic logo of issuer DCGO

The forward P/S indicator chart on GURU.Markets illustrates the development of DocGo Inc. (DCGO), which integrates digital management with mobile medical teams. The metric stands at 0.10, confirming the resilience of cash flows driven by government contracts and an asset-light model. However, political complexities regarding New York contracts and stringent regulatory oversight are creating pressure on revenues.

DCGO (docgo.com) Forward Price to Sales history from 07/04/2022 to 11/13/2026

DocGo, Inc - analytical breakdowns and key metrics (DCGO)

- current price and projected stock value:
Stock Price DocGo|DCGO - Analyst Target Range
- market capitalization data:
Market Value DocGo, Inc|DCGO - Total Enterprise Value
- book value of equity indicators:
Accounting Value per Share DocGo|DCGO - Accounting Value of Company|Market Capitalization to Book Value Ratio docgo.com|DCGO - Company Total Asset Base
- debt and liquidity data:
Debt to Equity DocGo Inc.|DCGO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital DocGo Inc.|DCGO - Company Total Debt|Debt to Book Value DocGo, Inc|DCGO - Long-Term Debt Volume|Company Short-Term Debts DocGo|Quick Ratio docgo.com
- net income and valuation multiples indicators:
DCGO - Net Income|Projected Future Earnings DocGo Inc.|DCGO - Market Cap to Net Income Ratio|Future Price to Earnings DocGo Inc|DCGO - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio DocGo, Inc|DCGO - Company profit before taxes, interest and amortization|Earnings per share for the last twelve months DocGo|DCGO - Earnings per share for the trailing year|Quarterly EPS earnings growth docgo.com|DCGO - Earnings per share growth rate in current year|Earnings growth forecast for next year DocGo Inc.
- company sales and revenue statistics:
DCGO - Revenue and Sales Volume|Company Future Sales Volume DocGo|DCGO - Market Cap to Sales Volume|Price-to-Projected Revenue Ratio DocGo, Inc
Analysis of all company metrics:DocGo (DCGO)
Original product of DocGo, Inc

Investors assess business growth potential through the ratio of market capitalization to projected sales volume, determining the extent of the premium paid for future cash flows. This forward revenue multiple divides the share price by expected turnover, reflecting how the market values the scalability of DocGo Inc. (DCGO) mobile medicine amid high capital costs and systemic demand for healthcare decentralization.

Analysis of competing companies

Forward P/S Multiple HCA (HCA Healthcare)|Projected Price to Revenue Tenet Healthcare Corp|FMS - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Solventum Health|EHC (Encompass Health) - Forward Price-to-Revenue Multiple|Universal Health Services, Inc. - Forward Price to Sales|DVA (DaVita) - Forward P/S Multiple|RadNet Inc (RDNT) - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Option Care Health Inc (OPCH)|Surgery Partners Group - Market Cap to Projected Revenue|Forward P/S Multiple PINC (Premier, Inc.)|EYE - Forward Price-to-Revenue Multiple|PGNY: Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Ardent Health ARDT|SEM: Forward P/S Multiple|Market Cap to Projected Revenue ASTH|MD (Pediatrix Corp) - Forward P/S Multiple|Forward Price-to-Revenue Multiple US Physical Therapy Inc (USPH)|Forward P/S Multiple PNTG|Organogenesis Holdings Inc. (ORGO) - Projected Price to Revenue|Price-to-Projected Revenue Ratio Nutex Health Corp NUTX|Auna Corp (AUNA) - Market Cap to Future Revenue Ratio|SBC: Forward Price-to-Revenue Multiple|evolus.com - Price to Expected Revenue Ratio|Community Health Systems, Inc. (CYH) - Price-to-Projected Revenue Ratio|BeautyHealth - Forward Price to Sales|MDWD (MediWound Ltd) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Biote Corporation BTMD|Forward P/S Multiple JYNT|Forward P/S Multiple p3hp.org (PIII)|Gain Therapeutics - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio EUDA (EUDA Health Holdings)|BMGL - Price-to-Projected Revenue Ratio|CollPlant Biotechnologies (CLGN) - Forward Price-to-Revenue Multiple|CUPR: Forward P/S Multiple|Market Cap to Future Revenue Ratio concordmedical.com (CCM)|Price-to-Projected Revenue Ratio American Shared Hospital Services|Market Cap to Projected Revenue MRM (MEDIROM Healthcare Group Inc.)|Forward Price-to-Revenue Multiple ALBT (Avalon GloboCare)|Price to Expected Revenue Ratio DHAI|Forward P/S Multiple XAGE (Longevity Health Holdings)|NIVF: Market Cap to Projected Revenue|ATIP - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio CareMax Inc.|KDLY: Forward P/S Multiple|Forward Price-to-Revenue Multiple ModivCare Corp|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|SSY - Projected Price to Revenue|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)